Cerilliant Corporation is providing chemical and biological reference standards, calibrators, reagents, supplies, and multi-component pain management products to the Defense Health Agency and Department of the Army Medical Command under a blanket purchase agreement and associated task order calls. The single award IDV was established with the Defense Health Agency for an overall value of $100,000 and period of performance through June 2026 to support drug testing and certification programs at...
Cerilliant Corporation was awarded a blanket purchase agreement by the Defense Health Agency to provide various medical and laboratory supplies and standards. The single award IDV has a potential value of $746,914.62 and period of performance through October 2027. Two firm fixed price BPA call orders have been issued against the IDV to date. The first, valued at $32,348.38, is for medical supplies with work conducted in Round Rock, Texas from July through September 2023. The second, valued at...
Cerilliant Corporation was awarded a single-award blanket purchase agreement from the Department of the Army Medical Command to supply chemical standards for forensic drug testing laboratories. With a potential value of $130,000 and period of performance through September 2022, this indefinite-delivery/indefinite-quantity contract vehicle provides chemicals and standards to support the Army's forensic toxicology drug testing mission. A firm fixed price call was also placed against this agreement...
This federal contract IDV, awarded by the Defense Health Agency (DHA) to National Medical Services, Inc. (doing business as NMS Labs), is for the provision of quantitative testing services. The single-award, $118,248 indefinite delivery contract has a period of performance running from September 15, 2020, through September 14, 2025. The contract originated from a solicitation seeking forensic toxicology testing services that the Division of Forensic Toxicology (DTF) was unable to provide...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Health Agency (DHA) to Sr-Services GMBH, a German-based for-profit company. The contract, valued at $166,686.64, is for the procurement of sensor cartridges for the detection of biological agents, lysergic acid diethylamide, and methamphetamine. Under this IDC, two firm fixed-price delivery orders have been issued to Sr-Services GMBH. The first order, valued at $49,971.44, is for the...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The contract has a ceiling value of $5,000,000 and a period of performance through September 16, 2029. Under this BPA, IDT will deliver a variety of custom oligonucleotides, including DNA and RNA, gene fragments, next-generation sequencing products, primers, probes, and...
The key details of this federal contract IDV award are as follows: The Defense Health Agency awarded a single-award indefinite delivery contract to Sigma-Aldrich, Inc., a foreign-owned, for-profit life science and high technology company, to provide stable isotope labeled water (18O, 10 atom%) for medical research programs. The contract has a ceiling value of $315,000 and a period of performance through May 18, 2028. Under this IDV, the Defense Health Agency placed a $63,000 firm fixed price...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Defense Health Agency to the prime contractor, Abbott Laboratories Inc. through its Abbott Diagnostics Division. The contract has a ceiling value of $625,000 and a period of performance through October 31, 2024. The purpose of the BPA is to provide the Defense Health Agency with a wide variety of Abbott Laboratories' medical reagents, diagnostic products, and automated analyzers to support clinical laboratory...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Health Care Logistics Inc. (HCL), a for-profit, Veteran-owned business. The BPA, valued at $1,500,000.00, allows DHA to procure a variety of medical supplies such as masks, towels, blankets, syringes, and gloves. Under this BPA, DHA has issued a $250,000.00 call order to HCL for the delivery of specialized pharmacy products, including admixtures, tamper-evident products, and spill...